1	Human	human	_	_	_	_	_	_	_
2	immunodeficiency	immunodeficiency	_	_	_	_	_	_	_
3	virus	virus	_	_	_	_	_	_	_
4	type-2	type-2	_	_	_	_	_	_	_
5	gene	gene	_	_	_	_	_	_	_
6	expression	expression	_	_	_	_	_	_	_
7	:	:	_	_	_	_	_	_	_
8	two	two	_	_	_	_	_	_	_
9	enhancers	enhancer	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	their	their	_	_	_	_	_	_	_
12	activation	activation	_	_	_	_	_	_	_
13	by	by	_	_	_	_	_	_	_
14	T-cell	t-cell	_	_	_	_	_	_	_
15	activators	activator	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	human	human	_	_	_	_	_	_	_
3	immunodeficiency	immunodeficiency	_	_	_	_	_	_	_
4	viruses	virus	_	_	_	_	_	_	_
5	(	(	_	_	_	_	_	_	_
6	HIVs	HIV	_	_	_	_	_	_	_
7	)	)	_	_	_	_	_	_	_
8	may	may	_	_	_	_	_	_	_
9	include	include	_	_	_	_	_	_	_
10	a	a	_	_	_	_	_	_	_
11	spectrum	spectrum	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	retroviruses	retrovirus	_	_	_	_	_	_	_
14	with	with	_	_	_	_	_	_	_
15	varying	vary	_	_	_	_	_	_	_
16	potential	potential	_	_	_	_	_	_	_
17	to	to	_	_	_	_	_	_	_
18	infect	infect	_	_	_	_	_	_	_
19	their	their	_	_	_	_	_	_	_
20	host	host	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	undergo	undergo	_	_	_	_	_	_	_
23	long	long	_	_	_	_	_	_	_
24	periods	period	_	_	_	_	_	_	_
25	of	of	_	_	_	_	_	_	_
26	latent	latent	_	_	_	_	_	_	_
27	infection	infection	_	_	_	_	_	_	_
28	,	,	_	_	_	_	_	_	_
29	and	and	_	_	_	_	_	_	_
30	induce	induce	_	_	_	_	_	_	_
31	pathology	pathology	_	_	_	_	_	_	_
32	.	.	_	_	_	_	_	_	_

1	Since	since	_	_	_	_	_	_	_
2	expression	expression	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	viruses	virus	_	_	_	_	_	_	_
6	is	be	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	large	large	_	_	_	_	_	_	_
9	part	part	_	_	_	_	_	_	_
10	regulated	regulate	_	_	_	_	_	_	_
11	by	by	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	sequence	sequence	_	_	_	_	_	_	_
14	elements	element	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	their	their	_	_	_	_	_	_	_
17	long	long	_	_	_	_	_	_	_
18	terminal	terminal	_	_	_	_	_	_	_
19	repeats	repeat	_	_	_	_	_	_	_
20	(	(	_	_	_	_	_	_	_
21	LTRs	LTR	_	_	_	_	_	_	_
22	)	)	_	_	_	_	_	_	_
23	,	,	_	_	_	_	_	_	_
24	this	this	_	_	_	_	_	_	_
25	study	study	_	_	_	_	_	_	_
26	was	be	_	_	_	_	_	_	_
27	directed	direct	_	_	_	_	_	_	_
28	to	to	_	_	_	_	_	_	_
29	an	an	_	_	_	_	_	_	_
30	analysis	analysis	_	_	_	_	_	_	_
31	of	of	_	_	_	_	_	_	_
32	the	the	_	_	_	_	_	_	_
33	regulatory	regulatory	_	_	_	_	_	_	_
34	elements	element	_	_	_	_	_	_	_
35	in	in	_	_	_	_	_	_	_
36	the	the	_	_	_	_	_	_	_
37	HIV-2	hiv-2	_	_	_	_	_	_	_
38	LTR	ltr	_	_	_	_	_	_	_
39	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	HIV-2	hiv-2	_	_	_	_	_	_	_
3	LTR	ltr	_	_	_	_	_	_	_
4	was	be	_	_	_	_	_	_	_
5	found	find	_	_	_	_	_	_	_
6	to	to	_	_	_	_	_	_	_
7	contain	contain	_	_	_	_	_	_	_
8	two	two	_	_	_	_	_	_	_
9	enhancers	enhancer	_	_	_	_	_	_	_
10	.	.	_	_	_	_	_	_	_

1	One	one	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	these	these	_	_	_	_	_	_	_
4	enhancers	enhancer	_	_	_	_	_	_	_
5	is	be	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	part	part	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	identical	identical	_	_	_	_	_	_	_
11	to	to	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	HIV-1	HIV-1	_	_	_	_	_	_	_
14	enhancer	enhancer	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	enhancer	enhancer	_	_	_	_	_	_	_
3	in	in	_	_	_	_	_	_	_
4	HIV-1	HIV-1	_	_	_	_	_	_	_
5	is	be	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	T-cell	t-cell	_	_	_	_	_	_	_
8	activation	activation	_	_	_	_	_	_	_
9	response	response	_	_	_	_	_	_	_
10	element	element	_	_	_	_	_	_	_
11	;	;	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	HIV-2	hiv-2	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	however	however	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	it	it	_	_	_	_	_	_	_
18	is	be	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	second	second	_	_	_	_	_	_	_
21	enhancer	enhancer	_	_	_	_	_	_	_
22	that	that	_	_	_	_	_	_	_
23	is	be	_	_	_	_	_	_	_
24	mainly	mainly	_	_	_	_	_	_	_
25	responsible	responsible	_	_	_	_	_	_	_
26	for	for	_	_	_	_	_	_	_
27	activation	activation	_	_	_	_	_	_	_
28	in	in	_	_	_	_	_	_	_
29	response	response	_	_	_	_	_	_	_
30	to	to	_	_	_	_	_	_	_
31	T-cell	t-cell	_	_	_	_	_	_	_
32	activators	activator	_	_	_	_	_	_	_
33	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	second	second	_	_	_	_	_	_	_
3	enhancer	enhancer	_	_	_	_	_	_	_
4	interacts	interact	_	_	_	_	_	_	_
5	with	with	_	_	_	_	_	_	_
6	two	two	_	_	_	_	_	_	_
7	nuclear	nuclear	_	_	_	_	_	_	_
8	binding	bind	_	_	_	_	_	_	_
9	proteins	protein	_	_	_	_	_	_	_
10	(	(	_	_	_	_	_	_	_
11	85	85	_	_	_	_	_	_	_
12	kD	kd	_	_	_	_	_	_	_
13	and	and	_	_	_	_	_	_	_
14	27	27	_	_	_	_	_	_	_
15	kD	kd	_	_	_	_	_	_	_
16	mobility	mobility	_	_	_	_	_	_	_
17	)	)	_	_	_	_	_	_	_
18	that	that	_	_	_	_	_	_	_
19	appear	appear	_	_	_	_	_	_	_
20	to	to	_	_	_	_	_	_	_
21	be	be	_	_	_	_	_	_	_
22	required	require	_	_	_	_	_	_	_
23	for	for	_	_	_	_	_	_	_
24	optimal	optimal	_	_	_	_	_	_	_
25	enhancer	enhancer	_	_	_	_	_	_	_
26	function	function	_	_	_	_	_	_	_
27	and	and	_	_	_	_	_	_	_
28	activation	activation	_	_	_	_	_	_	_
29	.	.	_	_	_	_	_	_	_

1	Observations	observation	_	_	_	_	_	_	_
2	such	such	_	_	_	_	_	_	_
3	as	as	_	_	_	_	_	_	_
4	these	these	_	_	_	_	_	_	_
5	encourage	encourage	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	speculation	speculation	_	_	_	_	_	_	_
8	that	that	_	_	_	_	_	_	_
9	there	there	_	_	_	_	_	_	_
10	may	may	_	_	_	_	_	_	_
11	be	be	_	_	_	_	_	_	_
12	subtle	subtle	_	_	_	_	_	_	_
13	differences	difference	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	regulation	regulation	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	HIV-1	HIV-1	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	HIV-2	hiv-2	_	_	_	_	_	_	_
21	expression	expression	_	_	_	_	_	_	_
22	that	that	_	_	_	_	_	_	_
23	may	may	_	_	_	_	_	_	_
24	be	be	_	_	_	_	_	_	_
25	relevant	relevant	_	_	_	_	_	_	_
26	to	to	_	_	_	_	_	_	_
27	the	the	_	_	_	_	_	_	_
28	possible	possible	_	_	_	_	_	_	_
29	longer	long	_	_	_	_	_	_	_
30	latency	latency	_	_	_	_	_	_	_
31	and	and	_	_	_	_	_	_	_
32	reduced	reduce	_	_	_	_	_	_	_
33	pathogenicity	pathogenicity	_	_	_	_	_	_	_
34	of	of	_	_	_	_	_	_	_
35	HIV-2	hiv-2	_	_	_	_	_	_	_
36	.	.	_	_	_	_	_	_	_

